Biomedical news

Vitro fertilization babies can grow well too!
Biomedical news 08.04.2024
Vitro fertilization babies can grow well too!

Many people believe that children conceived through in vitro fertilization (IVF) will not be at risk of birth defects, because they are made up of selected eggs and sperm. But that is not the case, "vitro fertilization babies" are still at risk of birth defects for many different reasons.

2021 through the vision of genetics
Biomedical news 08.04.2024
2021 through the vision of genetics

Genome research and applications are playing an irreplaceably important role in fighting the pandemic. And this year's breakthroughs will continue to improve human health against more than just Covid. Below are some of our achievements in the field of genetics.

The truth about Omicron? What scientists know so far
Biomedical news 05.04.2024
The truth about Omicron? What scientists know so far

COVID researchers are working at breakneck speed to learn about the variant's transmissibility, severity and ability to evade vaccines.

ctDNA: A novel adjuvant biomarker in resectable solid tumors
Biomedical news 04.04.2024
ctDNA: A novel adjuvant biomarker in resectable solid tumors

Circulating tumor DNA secreted into the blood by tumors has been shown to be a potent liquid biomarker for cancer.

CRISPR - A new route to produce antibiotics
Biomedical news 04.04.2024
CRISPR - A new route to produce antibiotics

New methods are urgently needed to develop new antibiotics. Now, scientists have developed a way to manipulate key assembly line enzymes in bacteria, using CRISPR-Cas9 gene editing, which could pave the way for the production of a generation of complex new antibiotics.

Omicron has the potential to weaken COVID vaccine protection
Biomedical news 03.04.2024
Omicron has the potential to weaken COVID vaccine protection

Early lab results suggest existing vaccines may be less effective against the fast-spreading coronavirus variant, but boosters should improve immunity. Fast-spreading Omicron SARS-CoV-2 variant is likely to compromise some vaccine protection, first studies suggest.

Using T cells to target malignant brain tumors
Biomedical news 01.04.2024
Using T cells to target malignant brain tumors

Doctors and scientists from the German Cancer Research Center (DKFZ) and from the Faculty of Medicine of the University of Heidelberg, Mannheim, have successfully tested the first tissue-specific neoantigen gene transfer immune cell therapy Test model on mice.

Why is Phacolab the best choice for testing?

High rate of accuracy

By the system of medical equipment from our world's leading technology partners

High-qualified equipment

Laboratory meets international standard ISO 15189:2022 providing high quality testing services

Rapid test result

Our 24/7 staff ensures customers receive timely results beyond your expectation

Phacolab testing procedure

With more than 15 years of operation and continuous improvement in Healthcare, we are confident in providing you a fast, effective and accurate testing process

01 Phacolab

Register for testing

Please register for provide your sample or contact us directly via our hotline for consultation

02 Phacolab

Handle your sample

Your sample will be received and transferred to Phacolab's laboratory

03 Phacolab

Analyze your sample

Our team of experienced experts will conduct the sample process with modern advanced technological equipment

04 Phacolab

Receive your result

Your test result will be sent to you as soon as possible

PHACOLAB DIAGNOSTIC COMPANY

Location: Level G2, B4 Kim Lien Building, Pham Ngoc Thach, Dong Da Dist., Ha Noi

Contact: 19003200

Email: info@phacolab.com

Chứng nhận đạt chuẩn quốc tế

- All Rights Reserved. Design by VNPedia